Try our Advanced Search for more refined results
February 06, 2018
Teva Pharmaceuticals International GmbH et al v. Eli Lilly and Company
Case Number:
1:18-cv-10242
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 27, 2018
Lilly Migraine Med's Uncertain Future Kills Teva's Patent Suit
A Massachusetts federal judge on Thursday cleared Eli Lilly and Co. from allegations that it infringed nine Teva Pharmaceuticals patents by preparing to launch a new migraine biologic, finding the suit is premature given that the U.S. Food and Drug Administration is still deciding whether to approve Lilly's drug.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login